Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Calcium dynamics in cardiac myocytes as a target of dichloromethane cardiotoxicity.

Authors
Hoffmann-P; Muller-SP; Heinroth-K; Buchner-E; Richards-D; Toraason-M
Source
Arch Toxicol 1996 Jan; 70(3-4):158-163
NIOSHTIC No.
00231627
Abstract
The purpose of the present study was to determine if cardiac actions of dichloromethane (DCM) in vivo correlate with in vitro alterations of Ca2+ dynamics in cardiac myocytes. Neonatal rat ventricular myocytes were obtained from 2- to 4-day-old rats, and electrically induced fluctuations of cytosolic free Ca2+ concentration ([Ca2+](i)) in single cardiomyocytes were investigated using spectrofluorometric analysis of fura-2-[Ca2+](i) binding. In cultured myocytes, cumulative exposure to 0.64-40.96 mM DCM resulted in a concentration-dependent and reversible decrease in the magnitude of [Ca2+](i) transients with IC10 and IC50 values of 7.98 and 18.82 mM, respectively. Total inhibition of [Ca2+](i) transients and cessation of beating were observed at 40.96 mM DCM. Suffusion with DCM for 40 min did not cause morphological alterations of the myocytes. In a urethane-anesthetized rat model, left ventricular pressure was measured by introducing a tip catheter via the carotid artery into the left ventricle, the ECG was recorded by two needle electrodes applied subcutaneously to the chest wall, and arterial pressure was measured via the femoral artery. Oral administration of 3.1-12.4mmol DCM/kg resulted in DCM blood concentrations between 1.0 and 1.6 mM, accompanied by a dose-dependent decrease in contractile force and heart rate without influencing blood pressure and ECG tracings. Moreover, DCM treatment provided significant protection against arrhythmia development due to CaCl2-infusion. In spite of the slight discrepancy between DCM blood concentrations and in vitro concentrations of DCM for [Ca2+](i) transient inhibition, present data are consistent with the view that cardiac effects after DCM exposure are mediated by alterations of Ca2+ dynamics during excitation-contraction coupling.
Keywords
Models; Physiology; Physiological-testing; Physiological-factors; Exposure-assessment; Chemical-properties; Chemical-hypersensitivity; Toxic-effects; Toxicopathology; Statistical-analysis; Cellular-function; Cellular-reactions; Cell-biology; Cell-damage; Cell-function; Biological-effects; Biological-factors; Laboratory-animals; Laboratory-testing; Cardiac-function; Cardiovascular-system-disorders; Myocardial-disorders; Myocardium; Muscle-cells; Muscle-tissue; Risk-factors; Chloromethanes; Solvents; Toxic-effects; Cardiac-function; Cell-function; In-vitro-studies; In-vivo-studies; Statistical-analysis; Author Keywords: Dichloromethane; Cardiotoxicity; [Ca2+]i transients; Myocardial contraction; Cardiac arrhythmia
Contact
Mark A. Toraason, Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupationa, Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, OH 45226
CODEN
ARTODN
CAS No.
75-09-2
Publication Date
19960101
Document Type
Journal Article
Fiscal Year
1996
NTIS Accession No.
NTIS Price
Issue of Publication
3-4
ISSN
0340-5761
NIOSH Division
DBBS; DART
Source Name
Archives of Toxicology
State
OH
TOP